title: Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
authors.affiliation: Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Uchida
authors.forename: Y
authors.initials: Y
authors.lastname: Tominaga
authors.forename: T
authors.initials: T
authors.lastname: Haba
authors.forename: T
authors.initials: T
authors.lastname: Katayama
authors.forename: S
authors.initials: S
authors.lastname: Matsuoka
authors.forename: T
authors.initials: T
authors.lastname: Sato
authors.forename: N
authors.initials: N
authors.lastname: Goto
authors.forename: A
authors.initials: A
authors.lastname: Takeda
authors.forename: K
authors.initials: K
authors.lastname: Morozumi
authors.forename: H
authors.initials: H
authors.lastname: Takagi
mesh_terms: D019540:Area Under Curve; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D016903:Drug Monitoring / Q000379:methods; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology; D016559:Tacrolimus / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D003404:Creatinine; D016559:Tacrolimus